Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05778786 · ClinicalTrials.gov registry record · NA
Design Validation of Toric Contact Lenses in Senofilcon A With a Blue-Blocking Chromophore
A NA study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 188
- Enrollment target
NCT05778786 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 188 participants.
The verdict
NCT05778786, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 188 participants
- Enrollment target
Study Summary
This will be a 4-visit, randomized, controlled, single-masked, bilateral wear, dispensing, 2-treatment, 2-sequence, 2-period crossover study.
Interventions
- DEVICE Acuvue Oasys 1 Day for Astigmatism
- DEVICE TRA100/TRA200 series toric contact lens with HEVL-blocking chromophore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 188 participants |
| Start Date | 2023-03-13 |
| Est. Completion | 2023-05-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05778786
The ClinicalTrials.gov registry entry for NCT05778786 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 188 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Acuvue Oasys 1 Day for Astigmatism is the first listed.
NCT05778786 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05778786 about?
NCT05778786 is a clinical study titled "Design Validation of Toric Contact Lenses in Senofilcon A With a Blue-Blocking Chromophore". This will be a 4-visit, randomized, controlled, single-masked, bilateral wear, dispensing, 2-treatment, 2-sequence, 2-period crossover study.
What is the current status of trial NCT05778786?
This trial is currently completed. It is a NA study. The enrollment target is 188 participants. The study started on 2023-03-13. Estimated completion is 2023-05-24.
What interventions are being tested in trial NCT05778786?
The interventions under investigation include: Acuvue Oasys 1 Day for Astigmatism (DEVICE), TRA100/TRA200 series toric contact lens with HEVL-blocking chromophore (DEVICE).
Who is sponsoring clinical trial NCT05778786?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.